期刊文献+

血液透析对尿毒症患者的IL-8表达的影响 被引量:1

INFLUENCE OF THE HEMODIALYSIS ON THE INTERLEUKIN-8 EXPRESSION IN THE UREMIC PATIENTS
下载PDF
导出
摘要 目的 :了解血透及不同透析膜对尿毒症患者IL - 8表达的影响。方法 :采用酶联免疫吸附试验 (ELISA)测定IL - 8血浆水平及测定PBMC培养上清液IL - 8水平。结果 :正常对照组、尿毒症非透析组及血透治疗组之间的IL - 8血浆水平均有显著性差异 ,聚砜膜组的IL - 8血浆水平低于铜仿膜组及铜氨膜组 ,而铜仿膜组及铜氨膜组之间无显著差异。血透患者透后的IL - 8血浆水平较血透前升高。血透患者的PBMC受LPS刺激后产生的IL - 8多于正常人及尿毒症未透析病人。结论 :血透可引起尿毒症患者IL - 8表达的异常 ,再生纤维素膜 (尤其是铜仿膜 )导致IL - 8血浆水平改变的能力强于聚砜膜 ,测量IL - 8表达有助于评价不同透析膜的生物相容性。 Objective:To investigate the influence of the hemodialysis and the different dialysis membranes on the interleukin-8 expression in the uremic patients.Method:The IL-8 of plasma concentration and supernate by the cultivated PBMC were measured with enzyme-linked immunoabsorbent assay ( ELISA ).Results:There was a significant difference among the plasma IL-8 level of the uremic patients on conservative therapy,that of the control group and that of the patients receiving hemodialysis. The IL-8 plasma level of the patients using the regenerated cellulose membrane (cuprophan CU, cuprammonium rayon CR) is higher than that of those using polysulfone ( PS ) membrane. The IL-8 plasma level was increased after hemodialysis.The production of IL-8 from PBMC of the patients underwent hemodialysis was more than that of normal subjects or uremic patients on conservative therapy.Conclusion:Hemodialysis can lead to the IL-8 abnormal expression in the uremic patients, it is more serious when the cellulose membrane (especially CU) is used. The measurement of IL-8 expression in PBMC is useful to evaluate the biocompatibility of dialysis membranes.
出处 《中国现代医学杂志》 CAS CSCD 2002年第20期59-61,共3页 China Journal of Modern Medicine
基金 广东省科委自然基金 (NO .960 615 ) 广州铁路集团公司科研开发项目 (NO .2 0 0 1-3 .3 6)资助
关键词 血液透析 尿毒症 IL-8 白细胞介素8 透析膜 Hemodialysis Intedeukin-8 Dialysis Membrane Uremia
  • 相关文献

参考文献9

  • 1Hakim RM. Clinical implications of hemodialysis membrane biocompatibility. Kidney Iht, 1993; 44(3): 484~494
  • 2Lazarus JM, Owen WF. Role of bioincompatibility m dialysis morbidity and mortality. Am J Kidney Dis, 1994; 24(6): 1019~ 1032
  • 3Pereira BJG, King AJ, Falagas ME, et al. Plasma levels of IL- I,TNFα and their specific inhibitors m undialyzed chronic renal failure.Kidney Int, 1994; 45:890~896
  • 4Pertosa G, Taranhno EA, Gesualdo L, et al. C5b- 9 generation and cytokine production in hemodialyzed patients. Kidney Int,1993; 43 (Suppl 41 ): S221~225
  • 5Memoli B, Rampino T, Libetta C, et al. Peripheral blood leukocytes interleukin - 6 production muremic hemodiatyzed patients (Abstract). J Am Soc Nephrol, 1990; 1:369
  • 6Ryan J, Beynon H, Rees AJ, et al. Evaluation of the in vitro production of tumor necrosis factor by monocytes m dialysis patients.Blood Purif, 1991; 9:142~ 147
  • 7Oettinger CW, Powell AC, Bland LA, et al. Enhanced release of tumor necrosis factor alpha but not mterleukin- I beta by uremic blood stimulated with endotoxin (Abstract)J Am Soc Nephrol,1990; 1:370
  • 8Donati D, Degiannis D, Raskova J, et al. Uremic remm effects on peripheral blood mononuclear cell and purified T lymphocyte responses. Kidney Iht, 1992; 42:681
  • 9Zaom P, Hakim RM. The effects of dialysis membrane on cytokine release. J Am Soc Nephrol,1994; 4:1711~1718

同被引文献4

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部